Research business

Global Invasive Fungal Infections Market Research Report 2022: Discoveries and Progress of Drugs and Plants in Pipeline – Forecast to 2027 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Invasive Fungal Infections Market: Global Industry Analysis, Trends, Market Size and Forecast to 2027” report has been added to from ResearchAndMarkets.com offer.

The report forecasts that the global invasive fungal infections market is expected to grow with a CAGR of 4% over the forecast period from 2021 to 2027.

The Global Invasive Fungal Infections Market report provides qualitative and quantitative analysis for the period 2019 to 2027. The Invasive Fungal Infections Market study covers the analysis of major geographies such as North America, Europe, Asia-Pacific and the right-of-way for the period from 2019 to 2027.

The Invasive Fungal Infections Market report is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts and trends of the global Invasive Fungal Infections market on the period from 2019 to 2027. Additionally, the report is a collective presentation of primary and secondary research findings.

Porter’s five forces model in the report provides insight into the competitive rivalry, market vendor and buyer positions, and opportunities for new entrants in the global Invasive Fungal Infections market over the period 2019 to 2027 Additionally, Growth Matrix has given in the report provides insight into investment areas that existing or new players in the market can consider.

Report results

1) Drivers

  • Discoveries and advances in drugs and facilities under development

  • An increase in the population suffering from HIV

  • Spectacular growth of the world economy

2) Constraints

  • Consequences that patients might face during immunosuppressive treatment of fungal infection

Company Profiles

  • Cidara, Basilea Pharmaceutica

  • Pfizer

  • GlaxoSmith Kline

  • Bayer AG

  • Abbott

  • Merck & Co.

  • Astellas Pharma Inc.

  • Scynexis Inc.

Segment covered

The Global Invasive Fungal Infections Market by Disease Type

  • Candidaemia Caa and invasive candidiasis

  • Intra-abdominal candidiasis

  • Cryptococcal meningitis

  • Esophageal candidiasis

  • Acute pulmonary histoplasmosis

  • Invasive aspergillosis

  • Invasive rhinosinusitis

  • Mucormycosis

  • Others

Global Invasive Fungal Infections Market by Drug Type

  • Polyenes

  • Amphotericin B Deoxycholate

  • Amphotericin B lipid formulation

  • Others

For more information on this report, visit https://www.researchandmarkets.com/r/i3v6pr